Switching From Oral Bisphosphonates to Bazedoxifene to Evaluate Effects on Bone Mineral Density in Postmenopausal Women

PHASE4CompletedINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions

Osteoporosis, Postmenopausal

Interventions

DRUG

Bazedoxifene

20 mg Oral daily for 12 months

DRUG

Calcium/Vit D

Calcium 500 mg / 400 IU Vit D

Trial Locations (3)

Gabinete Médico Velázquez, Madrid

Instituto Palacios, Madrid

Instituto de Ginecología EGR, Madrid